DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Biofil Chemicals & Pharmaceuticals Limited — Change in Management

NSE 2 hrs ago·11 Aug 2026, 1:09 pm

Company NSE

Biofil Chemicals & Pharmaceuticals Limited has announced that Mr. Ashok Kumar Ramawat will continue to serve as a Non-Executive Independent Director despite crossing the age limit of 75 years. This decision was formally communicated to the stock exchanges.

For investors, this development highlights the company's commitment to retaining experienced leadership and institutional knowledge. The board's decision to extend his tenure suggests confidence in his continued contribution to corporate governance and strategic oversight.

Investors should monitor the upcoming annual general meeting (AGM) for any formal resolutions regarding this extension and keep an eye on the company's future governance policies to understand how age-related tenure rules are being interpreted.